Emergence of resistance to acyclovir and penciclovir in varicella-zoster virus and genetic analysis of acyclovir-resistant variants (Q45751135)

15 December 2017

title

Emergence of resistance to acyclovir and penciclovir in varicella-zoster virus and genetic analysis of acyclovir-resistant variants (English)

1 reference

15 December 2017

1 reference

Ida M

1

1 reference

15 December 2017

Kageyama S

2

1 reference

15 December 2017

Sato H

3

1 reference

15 December 2017

Kamiyama T

4

1 reference

15 December 2017

Yamamura J

5

1 reference

15 December 2017

Kurokawa M

6

1 reference

15 December 2017

Morohashi M

7

1 reference

15 December 2017

Shiraki K

8

1 reference

15 December 2017

publication date

1 January 1999

1 reference

15 December 2017

published in

Antiviral Research

1 reference

15 December 2017

volume

40

1 reference

15 December 2017

issue

3

1 reference

15 December 2017

page(s)

155-166

1 reference

15 December 2017

In vitro susceptibility of varicella-zoster virus to acyclovir

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900057-6

7 January 2021

Phenotypic and genotypic characterization of acyclovir-resistant varicella-zoster viruses isolated from persons with AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900057-6

7 January 2021

Antiherpesvirus activity of 9-(4-hydroxy-3-hydroxy-methylbut-1-yl)guanine (BRL 39123) in cell culture

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900057-6

7 January 2021

Analysis of the thymidine kinase gene from clinically isolated acyclovir-resistant herpes simplex viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900057-6

7 January 2021

Growth Inhibition by Acycloguanosine of Herpesviruses Isolated from Human Infections

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900057-6

7 January 2021

The complete DNA sequence of varicella-zoster virus

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900057-6

7 January 2021

Mode of antiviral action of penciclovir in MRC-5 cells infected with herpes simplex virus type 1 (HSV-1), HSV-2, and varicella-zoster virus

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900057-6

7 January 2021

Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl) guanine

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900057-6

7 January 2021

Inhibitory action of acyclovir (ACV) and penciclovir (PCV) on plaque formation and partial cross-resistance of ACV-resistant varicella-zoster virus to PCV.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900057-6

7 January 2021

Prolonged cutaneous herpes zoster in acquired immunodeficiency syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900057-6

7 January 2021

A net +1 frameshift permits synthesis of thymidine kinase from a drug-resistant herpes simplex virus mutant

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900057-6

7 January 2021

Acyclovir-resistant varicella zoster virus infection after chronic oral acyclovir therapy in patients with the acquired immunodeficiency syndrome (AIDS).

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900057-6

7 January 2021

Nucleotide sequence changes in thymidine kinase gene of herpes simplex virus type 2 clones from an isolate of a patient treated with acyclovir

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900057-6

7 January 2021

Analysis of mutations in the thymidine kinase genes of drug-resistant varicella-zoster virus populations using the polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900057-6

7 January 2021

Virus drug-resistance: mechanisms and consequences

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900057-6

7 January 2021

Emergence of acyclovir-resistant varicella zoster virus in an AIDS patient on prolonged acyclovir therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900057-6

7 January 2021

Acyclovir resistant varicella zoster and HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900057-6

7 January 2021

Comparison of susceptibilities of varicella-zoster virus and herpes simplex viruses to nucleoside analogs

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900057-6

7 January 2021

In vitro and in vivo antiviral activity of 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil (BV-araU) and related compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900057-6

7 January 2021

Susceptibilities to aciclovir in viral isolates from children with varicella

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900057-6

7 January 2021

A point mutation in the thymidine kinase gene is responsible for acyclovir-resistance in herpes simplex virus type 2 sequential isolates

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900057-6

7 January 2021

An enzyme-linked immunoassay for the cartilage proteoglycan

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900057-6

7 January 2021

Foscarnet Therapy in Five Patients with AIDS and Acyclovir-resistant Varicella-Zoster Virus Infection

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900057-6

7 January 2021

Homopolymer mutational hot spots mediate herpes simplex virus resistance to acyclovir

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900057-6

7 January 2021

Molecular analysis of the pyrimidine deoxyribonucleoside kinase gene of wild-type and acyclovir-resistant strains of varicella-zoster virus

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900057-6

7 January 2021

Virus Particles and Glycoproteins Excreted from Cultured Cells Infected with Varicella-Zoster Virus (VZV)

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900057-6

7 January 2021

Immunochemical characterization of pyrimidine kinase induced by varicella-zoster virus

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900057-6

7 January 2021

Development of immunogenic recombinant Oka varicella vaccine expressing hepatitis B virus surface antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900057-6

7 January 2021

Differentiation of oka varicella vaccine strain from wild varicella-zoster virus strains isolated from vaccinees and household contact

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900057-6

7 January 2021

Comparison of antiviral assay methods using cell-free and cell-associated varicella-zoster virus

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900057-6

7 January 2021

Meningoradiculoneuritis due to acyclovir-resistant varicella zoster virus in an acquired immune deficiency syndrome patient

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900057-6

7 January 2021

Live vaccine used to prevent the spread of varicella in children in hospital

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900057-6

7 January 2021

Differential effects of famciclovir and valaciclovir on the pathogenesis of herpes simplex virus in a murine infection model including reactivation from latency

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900057-6

7 January 2021

10.1016/S0166-3542(98)00057-6

Identifiers

DOI

1 reference

15 December 2017

PubMed ID

10027650

1 reference

15 December 2017